Pharmafile Logo
Pharmafocus logo
Advanced Search
nerves

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

May 3, 2018
Research and Development Alzheimer's, dementia, pharma

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …

News
ecstasy_monogram

Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds

May 3, 2018
Research and Development MDMA, PTSD, pharma

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).

News
veeva_event

Speakers Announced for Veeva R&D Summit, Europe

May 3, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

In the pharma industry, we tend to use a lot of acronyms. Even in every day life, we are shortening …

News

Sandoz US woes continue with biosimilar rejection

May 3, 2018
Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …

News
jeremy_hunt

450,000 missed breast cancer screenings, 270 lives potentially shortened

May 2, 2018
Medical Communications Jeremy Hunt, NHS, UK, biotech, drugs, pharma, pharmaceutical

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s …

News

BMS pulls the plug on Phase 3 trials of IDO1 inhibitor

May 2, 2018
Research and Development BMS, Bristol-Myers Squibb, IDO1, opdivo, pharma, phase 3

Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …

News
20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018
Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …

News
aaron_traywick

Startup CEO who injected untested herpes cure during live stream found dead

May 2, 2018
Research and Development Aaron Traywick, Ascendance Biomedical, HIV, herpes, pharma

Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …

News
novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

News
praluentalirocumab_1211441

Sanofi/Regeneron forced to slash price in wake of slow sales

May 1, 2018
Research and Development, Sales and Marketing Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical, praluent

Sanofi and Regeneron were touted as having a sure-fire blockbuster on their hands when they first brought Praluent to market …

News
jon_neal-1_0

Takeda announces new UK MD, ahead of Shire transformation

May 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

Appointment
image_credit_porton_biopharma

Porton Biopharma opens new leukaemia drug production facility

May 1, 2018
Manufacturing and Production Porton Biopharma, leukaemia, pharma

Porton Biopharma Limited (PBL) has officially opened the doors of its new fermentation facility. John Glen, MP for Salisbury and …

News
ovariancancer

Ovarian cancer rates set to rise by 55%

May 1, 2018
Manufacturing and Production, Medical Communications biotech, drugs, ovarian cancer, pharma, pharmaceutical

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type …

News
credit_rich_s

United Therapeutics to acquire SteadyMed for $216 million

May 1, 2018
Manufacturing and Production, Sales and Marketing SteadyMed, UnitedTherapeutics, acquisition, pharma

United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive …

News
eye1

Novartis reveals more data for Eylea rival

May 1, 2018
Manufacturing and Production, Research and Development biotech, drugs, pharma, pharmaceutical

Building on the back of strong data released at the end of last year, Novartis has released further positive Phase …

News
gandhi

Lilly hires new leader of immuno-oncology

May 1, 2018
Manufacturing and Production, Medical Communications Eli Lilly, biotech, drugs, immunoconlogy, immunotherapy, pharma, pharmaceutical

Immuno-oncology has become a huge area of the oncology market, led by the wave of PD-1/L1 drugs that are reaping …

News
medopad

Connecting patients to doctors

April 30, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dan Vahdat, CEO and Co-founder of Medopad, discusses the rapid expansion of the app he helped develop, as its mobile …

Feature

EMA’s CHMP backs Roche’s Perjeta combo in HER2-positive breast cancer

April 30, 2018
Sales and Marketing Cancer, Herceptin, Perjeta, Roche, breast cancer, pharma

Roche’s Perjeta has edged one step closer to approval as a combo therapy after the EMA’s Committee for Medicinal Products …

News
piggy-2889042_960_720

Alzheon shies away from $81m IPO

April 30, 2018
Sales and Marketing Alzheon, biotech, drugs, pharma, pharmaceutical

Alzheon, a tiny biotech based in the Boston area, had initially launched its roadshow for an IPO potentially worth up …

News
allergan

Allergan unveils second bout of Phase 3 success in migraine

April 30, 2018
Research and Development, Sales and Marketing Allergan, migraine, pharma, ubrogepant

Allergan has revealed new data from the second of two Phase 3 studies into the efficacy of its calcitonin gene-related …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026